Mechanisms of methimazole cytotoxicity in isolated rat hepatocytes

Drug and Chemical Toxicology

Volumn 36, Issue 4, 2013, Pages 403-411

  Heidari, Reza ^a,b   Babaei, Hossein ^a,b   Eghbal, Mohammad ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Glutathione; Glyoxal; Hepatotoxicity; Methimazole; Mitochondria; N methylthiourea; ROS formation

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; GLYOXAL; HYDRALAZINE; METFORMIN; METHYLTHIOUREA; N,N DIMETHYLANILINE; REACTIVE OXYGEN METABOLITE; THIAMAZOLE; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; LIPID PEROXIDATION; LIVER CELL; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; RAT;

ANIMALS; CELL SURVIVAL; GLUTATHIONE; GLYOXAL; HEPATOCYTES; LIPID PEROXIDATION; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; METHIMAZOLE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; THIOUREA;

EID: 84883417924     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480545.2012.749272     Document Type: Article

References (46)

1. Anoush M, Eghbal MA, Fathiazad F, et al. (2009). The protective effects of garlic extract against acetaminophen-induced oxidative stress and glutathione depletion. Pak J Biol Sci 12:765-71.
2. Bergman U, Brittebo, EB. (1999). Methimazole toxicity in rodents: covalent binding in the olfactory mucosa and detection of glial fibrillary acidic protein in the olfactory bulb. Toxicol Appl Pharmacol 155:190-200.
3. Bergström U, Giovanetti A, Piras E, Brittebo EB. (2003). Methimazoleinduced damage in the olfactory mucosa: effects on ultrastructure and glutathione levels. Toxicol Pathol 31:379-87.
4. Blokhina O, Virolainen E, Fagerstedt KV. (2003). Antioxidants, oxidative damage, and oxygen deprivation stress: a review. Ann Bot 91:179-94.
5. Brittebo EB. (1995). Metabolism-dependent toxicity of methimazole in the olfactory nasal mucosa. Pharmacol Toxicol 76:76-9.
6. Damani LA, Nnane IP. (1996). The assessment of flavin-containing monooxygenase activity in intact animals. Drug Metabol Drug Interact 13:1-28.
7. Decker CJ, Doerge DR, Cashman J.R. (1992). Metabolism of benzimidazoline-2-thiones by rat hepatic microsomes and dog liver flavincontaining monooxygenase. Chem Res Toxicol 5:726-33.
8. Eghbal MA, Pennefather PS, O'Brien PJ. (2004). H2S cytotoxicity mechanism involves reactive oxygen species formation and mitochondrial depolarisation. Toxicology 203:69-76.
9. Franklyn JA. (2009). Thyroid gland: antithyroid therapy-best choice of drug and dose. Nat Rev Endocrinol 5:592-4.
10. Galati G, Tafazoli S, Sabzevari O, et al. (2002). Idiosyncratic NSAID drug induced oxidative stress. Chem Biol Interact 142:25-41.
11. Gallelli L, Staltari O, Palleria C, et al. (2009). Hepatotoxicity induced by methimazole in a previously health patient. Curr Drug Saf 4:204-6.
12. Genter MB, Deamer NJ, Blake BL, et al. (1995). Olfactory toxicity of methimazole: dose-response and structure-Activity studies and characterization of flavin-containing monooxygenase activity in the Long-Evans rat olfactory mucosa. Toxicol Pathol 23:477-86.
13. Grzywa M, Orlowska-Florek R, Grzywa-Celinska A. (2009). Two cases of serious hepatic injury caused by antithyroid drugs. [Article in Polish]. Endokrynol Pol 60:396-400.
14. Hengstmann JH, Hohn H. (1985). Pharmacokinetics of methimazole in humans. Klin Wochenschr 63:1212-17.
15. Jamshidzadeh A, Niknahad H, Kashafi H. (2007). Cytotoxicity of chloroquine in isolated rat hepatocytes. J Appl Toxicol 27:322-6.
16. Kedderis GL, Rickert DE. (1985). Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavincontaining monooxygenase. Drug Metab Dispos 13:58-61.
17. Khan S, O'Brien PJ. (1991). 1-bromoalkanes as new potent nontoxic glutathione depletors in isolated rat hepatocytes. Biochem Biophys Res Commun 179:436-41.
18. Kleinman WA, Richie Jr JP,. (2000). Status of glutathione and other thiols and disulfides in human plasma. Biochem Pharmacol 60:19-29.
19. Kroemer G, Galluzzi L, Brenner C. (2007). Mitochondrial membrane permeabilization in cell death. Physiol Rev 87:99-163.
20. Lebel CP, Ischiropoulos H, Bondy SC. (1992). Evaluation of the probe 20,70-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5:227-31.
21. Lee PW, Neal RA. (1978). Metabolism of methimazole by rat liver cytochrome P-450-containing monoxygenases. Drug Metab Dispos 6:591-600.
22. Livadas S, Xyrafis X, Economou F, et al. (2010). Liver failure due to antithyroid drugs: report of a case and literature review. Endocrine 38:24-8.
23. Mansuy D, Dansette PM. (2011). Sulfenic acids as reactive intermediates in xenobiotic metabolism. Arch Biochem Biophys 507:174-85.
24. Masubuchi Y, Nakayama S, Horie T. (2002). Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats. Hepatology 35:544-51.
25. Masubuchi Y, Yamada S, Horie T. (2000). Possible mechanism of hepatocyte injury induced by diphenylamine and its structurally related nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 292:982-7.
26. McGirr LG, Jatoe SD, O'Brien PJ. (1990). Myeloperoxidase catalysed cooxidative metabolism of methimazole: oxidation of glutathione and NADH by free radical intermediates. Chem Biol Interact 73:279-95.
27. Mehta R, Wong L, O'Brien PJ. (2009). Cytoprotective mechanisms of carbonyl scavenging drugs in isolated rat hepatocytes. Chem Biol Interact 178:317-23.
28. Mikhail NE. (2004). Methimazole-induced cholestatic jaundice. South Med J 97:178-82.
29. Mizutani T, Murakami M, Shirai M, et al. (1999). Metabolism-dependent hepatotoxicity of methimazole in mice depleted of glutathione. J Appl Toxicol 19:193-8.
30. Mizutani T, Yoshida K, Murakami M, et al. (2000). Evidence for the involvement of N-methylthiourea, a ring cleavage metabolite, in the hepatotoxicity of methimazole in glutathione-depleted mice: structure-toxicity and metabolic studies. Chem Res Toxicol 13:170-6.
31. Muriel P. (2009). Role of free radicals in liver diseases. Hepatol Int 3:526-36.
32. Poulsen LL, Hyslop RM, Ziegler DM. (1974). S-oxidation of thioureylenes catalyzed by a microsomal flavoprotein mixed-function oxidase. Biochem Pharmacol 23:3431-40.
33. Qu B, Li QT, Wong KP, et al. (2001). Mechanism of clofibrate hepatotoxicity: mitochondrial damage and oxidative stress in hepatocytes. Free Radic Biol Med 31:659-69.
34. Riener CK, Kada G, Gruber HJ. (2002). Quick measurement of protein sulfhydryls with Ellman's reagent and with 4,40-dithiodipyridine. Anal Bioanal Chem 373:266-76.
35. Saito C, Zwingmann C, Jaeschke H. (2010). Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-Acetylcysteine. Hepatology 51:246-54.
36. Schmidt G, Borsch G, Muller KM, Wegener M. (1986). Methimazoleassociated cholestatic liver injury: case report and brief literature review. Hepatogastroenterology 33:244-6.
37. Shangari N, O'Brien PJ. (2004). The cytotoxic mechanism of glyoxal involves oxidative stress. Biochem Pharmacol 68:1433-42.
38. Skellern GG, Steer S. (1981). The metabolism of [2-14C]methimazole in the rat. Xenobiotica 11:627-34.
39. Smith MT, Thor H, Hartizell P, Orrenius S. (1982). The measurement of lipid peroxidation in isolated hepatocytes. Biochem Pharmacol 31:19-26.
40. Tafazoli S, Spehar DD, O'Brien PJ. (2005). Oxidative stress mediated idiosyncratic drug toxicity. Drug Metab Rev 37:311-25.
41. Tephly TR, Hibbeln P. (1971). The effect of cobalt chloride administration on the synthesis of hepatic microsomal cytochrome P-450. Biochem Biophys Res Commun 42:589-95.
42. Tesfa D, Keisu M, Palmblad J. (2009). Idiosyncratic drug-induced agranulocytosis: possible mechanisms and management. Am J Hematol 84:428-34.
43. Valko M, Leibfritz D, Moncol J, et al. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84.
44. Woeber KA. (2002). Methimazole-induced hepatotoxicity. Endocr Pract 8:222-4.
45. Wondrak GT, Cervantes-Laurean D, Roberts MJ, et al. (2002). Identification of a-dicarbonyl scavengers for cellular protection against carbonyl stress. Biochem Pharmacol 63:361-73.
46. Xie F, Zhou X, Genter MB, et al. (2011). The tissue-specific toxicity of methimazole in the mouse olfactory mucosa is partly mediated through target-tissue metabolic activation by CYP2A5. Drug Metab Dispos 39:947-51.